A detailed history of Royal London Asset Management LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 239,639 shares of EW stock, worth $15.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
239,639
Previous 237,633 0.84%
Holding current value
$15.7 Million
Previous $22.7 Million 2.52%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$84.3 - $94.31 $169,105 - $189,185
2,006 Added 0.84%
239,639 $22.1 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $384,171 - $506,085
5,296 Added 2.28%
237,633 $22.7 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $334,900 - $422,003
-5,427 Reduced 2.28%
232,337 $17.7 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $607,932 - $819,409
8,775 Added 3.83%
237,764 $16.5 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $460,699 - $533,813
5,659 Added 2.53%
228,989 $21.6 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $42.7 Million - $48.6 Million
-575,184 Reduced 72.03%
223,330 $18.5 Million
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $877,176 - $1.12 Million
12,843 Added 1.63%
798,514 $59.6 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $2.4 Million - $3.13 Million
-29,182 Reduced 3.58%
785,671 $65 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $8.18 Million - $12.1 Million
94,587 Added 13.13%
814,853 $77.5 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $975,757 - $1.23 Million
9,570 Added 1.35%
720,266 $84.8 Million
Q4 2021

Oct 18, 2022

SELL
$106.37 - $130.68 $894,678 - $1.1 Million
-8,411 Reduced 1.17%
710,696 $92 Million
Q4 2021

Jan 18, 2022

SELL
$106.37 - $130.68 $894,678 - $1.1 Million
-8,411 Reduced 1.17%
710,696 $92 Million
Q3 2021

Oct 18, 2022

SELL
$102.91 - $122.75 $798,169 - $952,049
-7,756 Reduced 1.07%
719,107 $81.4 Million
Q3 2021

Nov 02, 2021

SELL
$102.91 - $122.75 $798,169 - $952,049
-7,756 Reduced 1.07%
719,107 $81.4 Million
Q2 2021

Oct 18, 2022

SELL
$83.84 - $104.76 $7.38 Million - $9.22 Million
-87,990 Reduced 10.8%
726,863 $75.3 Million
Q2 2021

Jul 14, 2021

SELL
$83.84 - $104.76 $786,754 - $983,067
-9,384 Reduced 1.27%
726,863 $75.3 Million
Q1 2021

Oct 17, 2022

SELL
$78.68 - $90.67 $6.18 Million - $7.13 Million
-78,606 Reduced 9.65%
736,247 $61.6 Million
Q1 2021

Apr 13, 2021

BUY
$78.68 - $90.67 $548,006 - $631,516
6,965 Added 0.96%
736,247 $61.6 Million
Q4 2020

Jan 29, 2021

BUY
$71.69 - $91.23 $52.3 Million - $66.5 Million
729,282 New
729,282 $66.5 Million
Q3 2020

Nov 04, 2020

SELL
$67.19 - $87.44 $29.3 Million - $38.1 Million
-436,005 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $16.7 Million - $22.3 Million
289,618 Added 197.84%
436,005 $29.6 Million
Q1 2020

May 01, 2020

BUY
$52.41 - $81.0 $983,683 - $1.52 Million
18,769 Added 14.71%
146,387 $28.8 Million
Q4 2019

Feb 05, 2020

BUY
$71.7 - $82.09 $3.28 Million - $3.76 Million
45,788 Added 55.96%
127,618 $29.7 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $5.04 Million - $6.17 Million
81,830 New
81,830 $18 Million
Q2 2019

Jul 31, 2019

SELL
$55.74 - $64.41 $4.75 Million - $5.49 Million
-85,281 Closed
0 $0
Q1 2019

Apr 30, 2019

SELL
$47.89 - $64.05 $262,724 - $351,378
-5,486 Reduced 6.04%
85,281 $0
Q4 2018

Jan 29, 2019

BUY
$46.41 - $56.94 $266,532 - $327,006
5,743 Added 6.75%
90,767 $13.7 Million
Q3 2018

Nov 08, 2018

SELL
$45.7 - $58.03 $74,673 - $94,821
-1,634 Reduced 1.89%
85,024 $0
Q2 2018

Sep 19, 2018

BUY
$42.45 - $51.3 $3.68 Million - $4.45 Million
86,658 New
86,658 $12.6 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.